Biological activity and mechanistic studies of andrimid

Journal of Antibiotics

Volumn 50, Issue 3, 1997, Pages 270-273

  Singh, Maya P ^a   Mroczenski Wildey, Mary Jo ^a,c   Steinberg, Deborah A ^a,d   Andersen, Raymond J ^b   Maiese, William M ^a   Greenstein, Michael ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c R W JOHNSON PHARMACEUTICAL RES I   (United States)

^d IntraBiotics Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDRIMID; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

EID: 0030942962     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.270     Document Type: Article

References (14)

1. FREDENHAGEN, A.; S. Y. TAMURA, P. T. M. KENNY, H. KOMURA, Y. NAYA, K. NAKANISHI, K. NISHIYAMA, M. SUGIURA & H. KITA: Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper. J. Am. Chem. Soc. 109: 4409-4411, 1987
2. NEEDHAM, J.; M. T. KELLY, M. ISHIGE & R. J. ANDERSEN: Andrimid and moiramides A to C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: Structure elucidation and biosynthesis. J. Org. Chem. 59: 2058-2063, 1994
3. OCLARIT, J. M.; H. OKADA, S. OHTA, K. KANIMURA, Y. YAMAOKA, T. IIZUKA, S. MIYASHIRO & S. IKEGAMI: Microbios. 78: 7-16, 1994
4. MCWORTHER, W.; A FREDENHAGEN, K. NAKANISHI & H. KOMURA: Stereocontrolled synthesis of andrimid and a structural requirement for the activity. J. Chem. Soc., Chem. Commun. 209-301, 1989
5. 2, a novel antibiotic produced by S. viridodiastaticus subsp. "litoralis' LL-31F508. Antimicrob. Agents Chemother. 38: 1808-1812, 1994
6. Worthington Enzyme Manual (V. WORTHINGTON, Ed.): RNA polymerase. Worthington Biochemical Corporation, Freehold, NJ. pp. 364-365, 1993
7. 14C-uracil into the metabolic pool and RNA. Biophys. J. 2: 35-47, 1962
8. KOMATSU, Y. & K. TANAKA: Mechanism of action of showdomycin Part I. Effects of showdomycin on the syntheses of nucleic acids and proteins in E. coli K12. Agr. Biol. Chem. 32: 1021-1027, 1968
9. NISHIMURA, H. & Y. KOMATSU: Reversal of inhibiting action of showdomycin on the proliferation of E. coli by nucleosides and thiol compounds. J. Antibiotics 21: 250-254, 1968
10. BECK, C. F.; J. NEUHARD, E. THOMASSEN, J. L. INGRAHAM & E. KLEKER: Salmonella typhimurium mutants defective in cytidine monophosphate kinase. J. Bacteriol. 120: 1370-1379, 1974
11. CHRISTOPH, B. F.; J. L. INGRAHAM, J. NEUHARD & E. THOMASSEN: Metabolism of pyrimidines and pyrimidine nucleosides by S. typhimurium. J. Bacteriol. 110: 219-228, 1972
12. LEUNG, K. & D. W. VISSER: Uridine and cytidine transport in E. coli B and transport deffcient mutants. J. Biol. Chem. 252: 2492-2497, 1977
13. SINGH, M. P.; P. J. PETERSON, N. V. JACOBUS, M. J. MROCZENSKI-WILDLY, W. M. MAIESE, M. GREENSTEIN & D. A. STEINBERG: Pyrroindomycins, novel antibiotics produced by "Streptomyces rugosporus" LL-42D005: II. Biological activities. J. Antibiotics 47: 1258-1265, 1994
14. KUBOTA, T.; T. TAKAHARA, M. NAGATA, T. FURUKAWA, S. KASE, H. TANINO, K. ISHIBIKI & M. KITAJIMA: Colorimetric chemosensitivity testing using sulforhodamine B. J. Surgical Oncology 52: 83-88, 1993